Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience-Reference-Cited by-同舟云学术

Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience

Published:2023-04 Issue: Volume:77 Page:101808
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Hoff Fieke W.,Chung Stephen S.,Patel Prapti A.,Premnath Naveen,Khatib Jude,Tadic-Ovcina Mirjana,AhmedRabie Abeer,Helton Debra,Yohannes Selamawit,Shahan Jaime,Patel Hetalkumari,Geethakumari Praveen Ramakrishnan,Vusirikala Madhuri,Collins Robert H.,Madanat Yazan F.

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference23 articles.

1. Post-transplantation cyclophosphamide for chimerism-based tolerance;McCurdy;Bone Marrow Transplant.,2019

2. Post-transplantation cyclophosphamide for tolerance induction in HLA-Haploidentical bone marrow transplantation;Luznik;Semin. Oncol.,2012

3. Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using Myeloablative Busulfan and Fludarabine conditioning;Kanakry;J. Clin. Oncol.,2014

4. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation;Mielcarek;Blood,2016

5. Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide;Luznik;Blood,2001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2024-06-10